<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Muscle Relaxants - Neuromuscular Blocking Drugs</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>
      
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterðŸ’œ</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>

    <h1>Muscle Relaxants - Neuromuscular Blocking Drugs</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->

    <div class="outline2">

      <input type="radio" name="control-2" id="show-2">
      <label for="show-2">Show Outline</label>
      <input type="radio" name="control-2" id="hide-2">
      <label for="hide-2">Hide Outline</label>
      <div class="contents">
        <ol>
          <li><a href="#header-1">Anatomy of the NMJ</a></li>
          <li><a href="#header-2">Physiology of Neuromuscular Transmission</a></li>
          <li><a href="#header-3">Factors Affecting Neuromuscular Transmission</a></li>
          <li><a href="#header-4">Characteristics of Ideal Muscle Relaxant</a></li>
          <li><a href="#header-5">Clasifications</a></li>
          <li><a href="#header-6">Assessment of neuromuscular transmission</a></li>
          <li><a href="#header-7">Muscle Relaxant Examples</a></li>
          <ul>
            <li><a href="#heading-7-1">SUXAMETHONIUM</a></li>
            <li><a href="#heading-7-2">D- TUBOCURARINE</a></li>
            <li><a href="#heading-7-3">PANCURONIUM</a></li>
            <li><a href="#heading-7-4">GALLAMINE</a></li>
            <li><a href="#heading-7-5">ATRACURIUM</a></li>
            <li><a href="#heading-7-6">CIS-ATRACURIUM</a></li>
            <li><a href="#heading-7-7">MIVACURIUM</a></li>
            <li><a href="#heading-7-8">VECURONIUM</a></li>
            <li><a href="#heading-7-9">ROCURONIUM</a></li>
            <li><a href="#heading-7-10">ALCURONIUM</a></li>
            <li><a href="#heading-7-11">DOXACURIUM</a></li>
            <li><a href="#heading-7-12">METOCURINE</a></li>
            <li><a href="#heading-7-13">PIPECURONIUM</a></li>

        </ul>
          <li><a href="#header-8">Reversal of NMB</a></li>

       </ol>
      </div>
     <div>


      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Anatomy of the Neuromuscular Junction (NMJ)</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Each motor nerve sends processes to each muscle fiber in the motor unit.</li>
                <li>Forming a highly organized and specialized structure called the neuromuscular junction, or motor endplate.</li>
                <li>The invagination of the muscle fiber sarcolemma forms the synaptic trough.</li>
                <li>The space between the axon terminal and the invaginated sarcolemma is called the synaptic cleft.</li>
            </ul>
            

                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/muscle-relaxants (1).png" alt="" onclick="openModal(this)">
                            <div class="caption"></div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption"></div>
                          </div>

                                      <!-- image here -->
            <div class="image-container">
                <img src="../figures/muscle-relaxants (2).png" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>


        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Physiology of Neuromuscular Transmission</a>
          </h2>
        </header>
        <div class='body'>
                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/muscle-relaxants (3).png" alt="" onclick="openModal(this)">
                            <div class="caption"></div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption"></div>
                          </div>



        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Factors Affecting Neuromuscular Transmission</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Muscle relaxants are potentiated by various factors:</li>
                <ul>
                    <li>Drugs:</li>
                    <ul>
                        <li>Most of the inhalational anesthetic agents</li>
                        <li>Aminoglycoside antibiotics, especially Gentamycin and Kanamycin</li>
                        <li>Î²-Blockers</li>
                        <li>Ca-channel blockers</li>
                    </ul>
                    <li>Electrolytes:</li>
                    <ul>
                        <li>Depressed Ca++</li>
                        <li>Raised Mg++</li>
                        <li>Raised K+</li>
                    </ul>
                    <li>Acidosis</li>
                    <li>Temperature:</li>
                    <ul>
                        <li>If temperature is depressed, then Suxamethonium is potentiated.</li>
                        <li>If temperature is raised, then Non-depolarizers are potentiated.</li>
                    </ul>
                    <li>Myasthenia gravis and other inherited muscle abnormalities (e.g., dystrophies, dystonias)</li>
                </ul>
                <li>Muscle contraction is controlled by motor neurons that release the neurotransmitter acetylcholine at neuromuscular junctions.</li>

                <li>Acetylcholine then diffuses across the narrow synaptic cleft and binds to acetylcholine receptors on the membrane of the muscle cell.</li>
                <li>Opening of ion channels within the receptor molecules, in such a way that a depolarizing, synaptic ion current can flow. This current triggers an all-or-nothing response in the form of an action potential across the plasma membrane of the muscle cells.</li>
                <li>The action potential moves out in all directions from the neuromuscular junctions, resulting in stimulation of the entire muscle fiber within a few milliseconds, and the contractile mechanism responds, causing the fiber to contract.</li>
            </ul>

            <h4>Depolarizing Neuromuscular Blockade</h4>
            <ul>
                <li>Acetylcholine Analogues Interact With Postjxnal Cholinergic-Nicotinic Receptor</li>
                <li>Depolarization Of Endplate And Muscle Fibre Then Muscle Contracts</li>
                <li>Contraction Is Not Sustained</li>
                <li>Persistent Occupation Of Receptors, Depolarization, Interruption Of Neuromuscular Transmission</li>
                <li>End Result Is Muscle Paralysis</li>
            </ul>
            
            <h4>Non-Depolarizing Neuromuscular Blockade</h4>
            <ul>
                <li>Combine Reversibly with Pjxnal Cholinergic-Nicotinic Receptors Without Opening Sodium Channels</li>
                <li>Competing with Acetylcholine Reducing the Receptors Available for ACh</li>
                <li>70% Occupancy Blocks Response of End-Plate Potential in Response to a Single Nv Impulse - Msc Remain Inert</li>
                <li>90-95% Occupancy Results in Complete Failure of NMT Hence Msc Become Flaccid</li>
            </ul>
            

        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Characteristics of an Ideal Muscle Relaxant</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Non-depolarizing</li>
                <li>Fast onset</li>
                <li>Free of cardiovascular side effects</li>
                <li>Easily antagonized</li>
                <li>Stable pharmacokinetic and pharmacodynamic properties in the presence of hepatic and renal diseases</li>
                <li>No such drug yet</li>
            </ul>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Classifications</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Depolarizing:</strong></li>
                <ul>
                    <li>Succinylcholine</li>
                    <li>Decamethonium (short-acting)</li>
                </ul>
                <li><strong>Non-depolarizing:</strong></li>
                <ul>
                    <li><strong>Aminosteroids (vagolysis):</strong></li>
                    <ul>
                        <li>Pancuronium</li>
                        <li>Vecuronium</li>
                        <li>Pipecuronium</li>
                        <li>Rocuronium</li>
                        <li>Rapacuronium</li>
                    </ul>
                    <li><strong>Benzylisoquinolinium:</strong></li>
                    <ul>
                        <li>D-tubocurarine</li>
                        <li>Atracurium</li>
                        <li>Doxacurium</li>
                        <li>Mivacurium</li>
                        <li>Cis-atracurium</li>
                        <li>Metocurine</li>
                        <li>Gallamine</li>
                    </ul>
                </ul>
            </ul>

            <h4>Classification of Non-Depolarizers</h4>
            <ul>
                <li><strong>Long Acting:</strong></li>
                <ul>
                    <li>d-tubocurarine</li>
                    <li>metocurine</li>
                    <li>doxacurium</li>
                    <li>pancuronium</li>
                    <li>gallamine</li>
                    <li>pipecuronium</li>
                </ul>
                <li><strong>Intermediate Acting:</strong></li>
                <ul>
                    <li>atracurium</li>
                    <li>cis-atracurium</li>
                    <li>vecuronium</li>
                    <li>rocuronium</li>
                </ul>
                <li><strong>Short Acting:</strong></li>
                <ul>
                    <li>mivacurium</li>
                    <li>rapacuronium</li>
                </ul>
            </ul>

            <h4>Differences Btw Depolarisers And Non Depolarizers</h4>

                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/muscle-relaxants (4).png" alt="" onclick="openModal(this)">
                            <div class="caption"></div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption"></div>
                          </div>
            

        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Assessment of Neuromuscular Transmission</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>CLINICAL:</strong> Requires a conscious and cooperative patient</li>
                <ul>
                    <li>Sustained head lift for 5 seconds</li>
                    <li>Firm hand grip for 5 seconds</li>
                    <li>Vital capacity breath of >10ml/kg</li>
                    <li>Inability to perform this with see-sawing respiration indicates residual neuromuscular blockade</li>
                </ul>
                <li><strong>PERIPHERAL NERVE STIMULATION:</strong> Used in anesthetized patients</li>
            </ul>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> Muscle Relaxant Examples</a>
          </h2>
        </header>
        <div class='body'>
           
            <section id='heading-7-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-1'>SUXAMETHONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Chemical Structure:</strong> 2 molecules of Acetyl Choline linked together with 2 quaternary amine groups.</li>
                        <li><strong>Physical Properties:</strong> It is available in 2 forms:</li>
                        <ul>
                            <li>Succinylcholine chloride - Aqueous - Temperate</li>
                            <li>Succinylcholine bromide - Powder - Tropic</li>
                        </ul>
                        <li><strong>Rapid onset, short duration:</strong> 3-5 minutes</li>
                        <li><strong>Indications:</strong> To facilitate endotracheal tube (ETT) placement</li>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>Intubating dose in adults is 1mg/kg</li>
                            <li>X-ray examinations, especially in infants, is 1.5-2.0mg/kg</li>
                        </ul>
                        <li><strong>Rapidly hydrolyzed by plasma cholinesterase</strong></li>
                    </ul>
                    
                    <h4>SIDE-EFFECTS</h4>
                    <ul>
                        <li>Cardiac arrhythmias:</li>
                        <ul>
                            <li>Sinus bradycardia</li>
                            <li>Ventricular premature beats</li>
                        </ul>
                        <li>Hyperkalemia, especially in:</li>
                        <ul>
                            <li>Patients with massive burns</li>
                            <li>Muscle trauma</li>
                            <li>Upper motor neuron lesions (UMNL) and lower motor neuron lesions (LMNL)</li>
                            <li>Renal disease</li>
                            <li>Severe abdominal infections</li>
                        </ul>
                        <li>Raised Intraocular Pressure (IOP)</li>
                        <li>Raised Intracranial Pressure (ICP)</li>
                        <li>Raised Intragastric Pressure (IGP)</li>
                        <li>Scoline pain, particularly in ambulant and muscular patients</li>
                        <li>Anaphylactoid reaction</li>
                        <li>Masseter spasm, which could herald Malignant Hyperthermia (MH)</li>
                    </ul>

                    <h4>CAUSES OF PROLONGATION OF ACTION IN PLASMACHOLINESTERASE DEFICIENCY</h4>
                    <ul>
                        <li>Physiological</li>
                        <li>Pregnancy</li>
                        <li>Contraceptive pills</li>
                        <li>Malnutrition</li>
                        <li>Liver disease (cirrhosis)</li>
                        <li>Hemodialysis</li>
                        <li>Echothiopate (an eye drop)</li>
                    </ul>
                    
                    
                </div>
            </section>

            <section id='heading-7-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-2'>D-TUBOCURARINE</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>First NMB Agent Used in Anesthesia</li>
                        <li>It Causes Muscle Paralysis Within 3 Minutes</li>
                        <li>Duration = 30-40 Minutes (Long Acting)</li>
                        <li>Causes Hypotension by Two Mechanisms:</li>
                        <ul>
                            <li>Sympathetic Ganglionic Blockage</li>
                            <li>Histamine Release</li>
                        </ul>
                        <li>Metabolized in the Liver and Excreted by Kidney</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-3'>PANCURONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Is an Aminosteroid Muscle Relaxant Acting Within 2 Minutes</li>
                        <li>Recommended Loading Dose Within 0.06-0.08 mg/kg</li>
                        <li>Increment of 0.01-0.02 mg/kg</li>
                        <li>Large Amount Bound to Plasma Protein</li>
                        <li>Dependent on Renal Excretion (80%)</li>
                        <li>Metabolized and Excreted by the Liver</li>
                        <li>Does Not Release Histamine</li>
                        <li>Cardiovascular System Effects:</li>
                        <ul>
                            <li>Increases Blood Pressure Due to Norepinephrine Release</li>
                            <li>Sinus Tachycardia Due to Its Vagolysis Effect</li>
                        </ul>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-4'>GALLAMINE</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Solely Excreted by the Kidney, Hence Absolutely Contraindicated in Renal Disease</li>
                        <li>Crosses the Placenta, Hence Contraindicated in Obstetrics</li>
                        <li>Vagolytic, Causing Early, Severe Tachycardias</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-5'>ATRACURIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.3-0.4 mg/kg or 30 mg increment 0.08-0.1 mg/kg</li>
                        </ul>
                        <li><strong>Amps:</strong> 2.5 ml = 25 mg</li>
                        <li>Cardiovascularly stable, but larger doses release histamine with mild hypotension</li>
                        <li>Breakdown occurs spontaneously and is dependent on pH and Temperature (Hoffman degradation).</li>
                        <li>Hepatic degradation also occurs resulting in the formation of Laudanosine.</li>
                        <ul>
                            <li>Laudanosine is a convulsant in high doses but clinically has not been a problem.</li>
                        </ul>
                        <li>It is safe in hepatic and renal failure.</li>
                        <li>Non-cumulative, even after prolonged infusions.</li>
                        <li>Similar duration of action to Vecuronium.</li>
                        <li>Expensive</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-6'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-6'>CIS-ATRACURIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.15 mg/kg or 10 mg</li>
                        </ul>
                        <li><strong>Amps:</strong> 5 ml = 10 mg</li>
                        <li>Features:</li>
                        <ul>
                            <li>Similar to Atracurium without the histamine release.</li>
                        </ul>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-7'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-7'>MIVACURIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.15 mg/kg or 10 mg</li>
                        </ul>
                        <li><strong>Amps:</strong> 5 ml = 10 mg and 10 ml = 20 mg</li>
                        <li>New on the market</li>
                        <li>Much shorter acting than the previous 2 agents (approximately 10 minutes), with rapid recovery. It will not replace Suxamethonium.</li>
                        <li>Degraded by plasma cholinesterase (competing with Suxamethonium) and thus contraindicated in patients with "Scoline Apnoea."</li>
                        <li>May be used as an infusion</li>
                        <li>Expensive</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-8'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-8'>VECURONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.1 mg/kg or 6 mg</li>
                        </ul>
                        <li><strong>Amps:</strong> 2 ml = 4 mg and 10 ml = 20 mg as a dry powder needing reconstituting with sterile water</li>
                        <li>Cardiovascularly very stable, with occasional bradycardia</li>
                        <li>No histamine release</li>
                        <li>Shorter acting (approximately half the duration of the preceding drugs)</li>
                        <li>Hepato-biliary excretion and can thus be used in renal failure</li>
                        <li>Expensive</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-9'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-9'>ROCURONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.3 - 0.9 mg/kg or 20 - 50 mg</li>
                        </ul>
                        <li><strong>Amps:</strong> 5 ml = 50 mg and 10 ml = 100 mg</li>
                        <li>New on the market</li>
                        <li>Low dose provides slow intubation and short duration (approximately 15 minutes). High dose provides very fast intubation (approximately 60 - 90 seconds) and long duration.</li>
                        <li>Cardiovascularly stable with a mild increase in heart rate and blood pressure</li>
                        <li>Very rapid onset (similar to, but not as predictable as Suxamethonium) but has an intermediate to long duration of action.</li>
                        <li>Undergoes no metabolism and is primarily eliminated by the liver and slightly by the kidney</li>
                        <li>Expensive</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-10'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-10'>ALCURONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Dose:</strong></li>
                        <ul>
                            <li>0.25 mg/kg or 15 mg</li>
                        </ul>
                        <li><strong>Amps:</strong> 2 ml = 10 mg</li>
                        <li>Cardiovascularly more stable, with occasional tachycardia</li>
                        <li>Histamine release with possible mild hypotension</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-11'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-11'>DOXACURIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Benzylisoquinoline compound closely related to mivacurium and atracurium</li>
                        <li>Most potent currently</li>
                        <li>Onset: 10 minutes</li>
                        <li>Duration: 3 hours</li>
                        <li>Eliminated unchanged by the kidney</li>
                        <li>Slightly metabolized by plasma cholinesterase</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-12'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-12'>METOCURINE</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Bis-quaternary amine derivative of DTC</li>
                        <li>Pharmacology similar to DTC</li>
                    </ul>
                    
                </div>
            </section>

            <section id='heading-7-13'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-13'>PIPECURONIUM</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Elimination depends on renal (70%) and secondarily biliary (20%).</li>
                        <li>Principal advantage over pancuronium is its lack of cardiovascular side effects due to a decreased binding to cardiac muscarinic receptors.</li>
                    </ul>
                    
                </div>
            </section>
        </div>
      </section>


      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Reversal of NMB</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Acetyl Choline is normally degraded in milliseconds by Cholinesterases. The degradation of Acetyl Choline may be inhibited by the use of an Acetyl Cholinesterase inhibitors, e.g.,</li>
                <ul>
                    <li>Edrophonium</li>
                    <li>Pyridostigmine</li>
                    <li>Neostigmine</li>
                    <li>Physostigmine</li>
                </ul>
                <li>Acetyl Choline is the neuro-transmitter at numerous receptors, and the use of an Acetyl Cholinesterase inhibitor will result in an increase in Acetyl Choline at all cholinergic receptors (pre- and post-ganglionic Parasympathetic nerves, as well as pre-ganglionic Sympathetic nerves).</li>
                <li>The effects of relative overactivity of Acetyl Choline that would result if a Muscarinic blocker were not given at the same time includes the following:</li>
                <ul>
                    <li>Severe bradycardia</li>
                    <li>Bronchospasm</li>
                    <li>Copious secretions</li>
                    <li>Other parasympathetic effects, e.g., increased gut motility, pupil constriction, etc.</li>
                </ul>
                <li>The standard reversal "cocktail" for an adult is, therefore, a mixture of:</li>
                <ul>
                    <li>Neostigmine 2.5 mg plus Atropine 1.0 - 1.2 mg</li>
                    <li>Or Neostigmine 2.5 mg plus Glycopyrrolate 0.4 - 0.6 mg, mixed in the same syringe.</li>
                </ul>
            </ul>
            
        </div>
      </section>




      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

      
                <div class="comment">
        <p>Send your comments, corrections, explanations/clarifications and requests/suggestions to our <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">WhatsApp group</a>.</p>
        </div>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this â€˜Websiteâ€™, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiðŸ‘‹</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
